0001701272-17-000001.txt : 20170330 0001701272-17-000001.hdr.sgml : 20170330 20170330150045 ACCESSION NUMBER: 0001701272-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170330 DATE AS OF CHANGE: 20170330 EFFECTIVENESS DATE: 20170330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Verseau Therapeutics, Inc. CENTRAL INDEX KEY: 0001701272 IRS NUMBER: 815332369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-283695 FILM NUMBER: 17725281 BUSINESS ADDRESS: STREET 1: C/O FOLEY HOAG LLP STREET 2: 155 SEAPORT BLVD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6178321000 MAIL ADDRESS: STREET 1: C/O FOLEY HOAG LLP STREET 2: 155 SEAPORT BLVD CITY: BOSTON STATE: MA ZIP: 02210 D 1 primary_doc.xml X0707 D LIVE 0001701272 Verseau Therapeutics, Inc. 2000 Commonwealth Avenue Suite 200 Auburndale MA MASSACHUSETTS 02466 617-244-9050 DELAWARE None None Corporation true 2017 Daniel Anderson 2000 Commonwealth Avenue Suite 200 Auburndale MA MASSACHUSETTS 02466 Executive Officer Director Promoter Robert Langer 2000 Commonwealth Avenue Suite 200 Auburndale MA MASSACHUSETTS 02466 Director Promoter Christine Bunt 2000 Commonwealth Avenue Suite 200 Auburndale MA MASSACHUSETTS 02466 Executive Officer Director Jong Chang 2000 Commonwealth Avenue Suite 200 Auburndale MA MASSACHUSETTS 02466 Director Walter Capone 2000 Commonwealth Avenue Suite 200 Auburndale MA MASSACHUSETTS 02466 Executive Officer Other Health Care Decline to Disclose 06b false 2017-03-15 false true false 0 11450000 4300000 7150000 The additional $7,150,000 worth of securities in this offering will be sold to the existing investors upon the achievement of certain milestone events of the Issuer. false 5 0 0 0 true Proceeds are for working capital. The number above excludes use of proceeds for normal salary and bonus to executive officers. false Verseau Therapeutics, Inc. /s/ Christine Bunt Christine Bunt Chief Executive Officer 2017-03-30